Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.
Press releases published on September 21, 2025
Docufraud Laboratory Announces Expert Digital Analysis of Documents and Personal Devices
Forensics is used to confirm if a document has been backdated, or altered after signing. The Analysis of unwanted images, video’s, texts or email messages. TORONTO, CANADA, September 21, 2025 /EINPresswire.com/ -- Docufraud Forensic Laboratory is …
FexaAI : la suite IA tout-en-un lancée par GENISOFT WEB
Plateforme française basée à Échirolles : rédaction SEO, images, vidéo IA et posts sociaux — le tout au même endroit pour produire mieux, plus vite. ECHIROLLES, AUVERGNE-RHôNE-ALPES, FRANCE, September 21, 2025 /EINPresswire.com/ -- FexaAI, la plateforme …
Uzbekistan’s emerging startup ecosystem: a rising global innovation platform
NEW-YORK, NY, UNITED STATES, September 20, 2025 /EINPresswire.com/ -- Five years ago, the startup ecosystem in Uzbekistan was said to be fledgling. Today's fast-changing market is defined by a consistent increase in investment activity, the opening of …
Patients Taking AUSTEDO XR® (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR® (deutetrabenazine) extended-release tablets Patients reported high satisfaction (>89%) with AUSTEDO XR, with 96% …
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with olanzapine LAI (TEV-'749) and its long-term systemic safety profile was consistent with other olanzapine …